| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Sykes M | |
| P2860 | cites work | Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2----P1) irradiation chimeras | Q69069387 |
| Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells | Q70897701 | ||
| Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body | Q71023299 | ||
| Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance | Q71463405 | ||
| Donor-type microchimerism associated with graft rejection eight years after liver transplantation | Q72759415 | ||
| Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning | Q73910639 | ||
| Porcine stem cell engraftment and seeding of murine thymus with class II+ cells in mice expressing porcine cytokines: toward tolerance induction across discordant xenogeneic barriers | Q74052919 | ||
| Role of intrathymic rat class II+ cells in maintaining deletional tolerance in xenogeneic rat-->mouse bone marrow chimeras | Q74593319 | ||
| Altered expression of Ly-49 receptors on NK cells developing in mixed allogeneic bone marrow chimeras | Q77786390 | ||
| Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates | Q77890140 | ||
| Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism | Q78237930 | ||
| Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death | Q31838891 | ||
| Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen | Q33499668 | ||
| Efficacy of adhesive interactions in pig-to-human xenotransplantation | Q33667795 | ||
| Mixed chimerism as an approach for the induction of transplantation tolerance | Q33729964 | ||
| Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection | Q33853565 | ||
| Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection | Q33903407 | ||
| The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection | Q33904114 | ||
| Cell migration, chimerism, and graft acceptance | Q34178622 | ||
| Evidence for the presence of multilineage chimerism and progenitors of donor dendritic cells in the peripheral blood of bone marrow-augmented organ transplant recipients | Q34240252 | ||
| Graft-versus-host-related immunosuppression is induced in mixed chimeras by alloresponses against either host or donor lymphohematopoietic cells | Q36355759 | ||
| Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen | Q36355970 | ||
| Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation | Q36361906 | ||
| Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice | Q36365670 | ||
| Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene | Q36380455 | ||
| Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism | Q36400683 | ||
| Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance | Q36401145 | ||
| Genetic control of natural killing and in vivo tumor elimination by the Chok locus | Q36401390 | ||
| On the role of thymic epithelium vs. bone marrow-derived cells in repertoire selection of T cells | Q36415831 | ||
| Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. | Q36417432 | ||
| Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model | Q37174844 | ||
| Mixed chimerism and tolerance without whole body irradiation in a large animal model | Q37202108 | ||
| Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. | Q37382702 | ||
| Maintenance of in vivo tolerance by persistence of antigen | Q41828244 | ||
| Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies | Q43505338 | ||
| Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen | Q47784478 | ||
| Outcomes of recipients of both bone marrow and solid organ transplants. A review. | Q52905809 | ||
| Both gamma delta T cells and NK cells inhibit the engraftment of xenogeneic rat bone marrow cells and the induction of xenograft tolerance in mice. | Q54024213 | ||
| Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. | Q54073234 | ||
| Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment | Q56906119 | ||
| Pancreatic islet xenograft tolerance after short-term costimulation blockade is associated with increased CD4+ T cell apoptosis but not immune deviation | Q56906134 | ||
| Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance | Q56906585 | ||
| Role of peripheral clonal deletion in tolerance induction with bone marrow transplantation and costimulatory blockade | Q56907245 | ||
| Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment | Q56907406 | ||
| Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways | Q56908985 | ||
| Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance | Q57202280 | ||
| Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts | Q59068399 | ||
| Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance | Q59074162 | ||
| Cutting Edge: Anti-CD154 Therapeutic Antibodies Induce Infectious Transplantation Tolerance | Q61651670 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 417-424 | |
| P577 | publication date | 2001-04-01 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | Mixed chimerism and transplant tolerance | |
| P478 | volume | 14 |
| Q37729199 | 2-Gy whole-body irradiation significantly alters the balance of CD4+CD25−T effector cells and CD4+CD25+Foxp3+T regulatory cells in mice |
| Q44405380 | A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic nod mice |
| Q33209271 | Ability of donor splenocytes with costimulation blockade to induce mixed hematopoietic chimerism and transplantation tolerance |
| Q37873555 | Achievements and challenges in composite tissue allotransplantation |
| Q77369489 | Achieving clinical transplant tolerance: what are the hurdles? |
| Q48074139 | Achieving immune tolerance in hand and face transplantation: a realistic prospect? |
| Q37324329 | Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II. |
| Q35673668 | Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation |
| Q53225655 | An instructive role of donor macrophages in mixed chimeras in the induction of recipient CD4(+)Foxp3(+) Treg cells. |
| Q47593845 | Ancient proteins and futuristic surgery: the role of complement in discordant xenograft rejection |
| Q35892241 | Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions |
| Q42152223 | Association of mixed hematopoietic chimerism with elevated circulating autoantibodies and chronic graft-versus-host disease occurrence |
| Q35615856 | Attenuation of phagocytosis of xenogeneic cells by manipulating CD47. |
| Q44695042 | Bcl-XL expression in stem cells facilitates engraftment and reduces the need for host conditioning during bone marrow transplantation |
| Q37320975 | Bone marrow T cells are superior to splenic T cells to induce chimeric conversion after non-myeloablative bone marrow transplantation |
| Q24529963 | CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells |
| Q37781118 | CD47 in xenograft rejection and tolerance induction |
| Q37157989 | CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance |
| Q35216462 | Can tolerogenic dendritic cells help to modulate allo-immune responses in the setting of hematopoietic cell transplantation? |
| Q37008459 | Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy |
| Q33613197 | Cell fusion of bone marrow cells and somatic cell reprogramming by embryonic stem cells |
| Q36672119 | Cell replacement therapy and the evasion of destructive immunity |
| Q34974448 | Challenges in the pursuit of immune tolerance. |
| Q34387873 | Challenges to achieving clinical transplantation tolerance |
| Q56939086 | Characterization of Tolerance Induction through Prenatal Marrow Transplantation: The Requirement for a Threshold Level of Chimerism to Establish Rather than Maintain Postnatal Skin Tolerance |
| Q36738630 | Chemically induced skin carcinogenesis: Updates in experimental models (Review). |
| Q35730793 | Clinical islet transplantation: advances and immunological challenges |
| Q34874199 | Clinical xenotransplantation: pigs might fly? |
| Q51494710 | Combined Anti-CD154/CTLA4Ig Costimulation Blockade-Based Therapy Induces Donor-Specific Tolerance to Vascularized Osteomyocutaneous Allografts. |
| Q92735571 | Combined kidney and hematopoeitic cell transplantation to induce mixed chimerism and tolerance |
| Q47100613 | Combining Adoptive Treg Transfer with Bone Marrow Transplantation for Transplantation Tolerance |
| Q37661374 | Cross-immune tolerance: conception and its potential significance on transplantation tolerance |
| Q39013210 | Curative haploidentical BMT in a murine model of X-linked chronic granulomatous disease. |
| Q36692524 | Current progress in xenogeneic tolerance |
| Q34740521 | Dendritic cells, tolerance induction and transplant outcome |
| Q37957143 | Developing immunologic tolerance for transplantation at the fetal stage. |
| Q51974471 | Different mechanisms control peripheral and central tolerance in hematopoietic chimeric mice. |
| Q34595629 | Distinct requirements for achievement of allotolerance versus reversal of autoimmunity via nonmyeloablative mixed chimerism induction in NOD mice |
| Q79829285 | Donor double-negative Treg promote allogeneic mixed chimerism and tolerance |
| Q45068443 | Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft |
| Q47844461 | Double negative Treg cells promote nonmyeloablative bone marrow chimerism by inducing T-cell clonal deletion and suppressing NK cell function |
| Q56902663 | Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation |
| Q43198292 | Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning |
| Q35116124 | Embryonic stem cells and potency to induce transplantation tolerance |
| Q53026981 | Evaluation of epithelial chimerism after bone marrow mesenchymal stromal cell infusion in intestinal transplant patients. |
| Q27005853 | Face allotransplantation and burns: a review |
| Q35724702 | Feasibility of xeno-transplantation |
| Q36689232 | From current immunosuppressive strategies to clinical tolerance of allografts |
| Q35106120 | Gene Therapy Progress and Prospects: Gene therapy in organ transplantation |
| Q83797705 | Gene therapy in transplantation |
| Q34028508 | Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells |
| Q35539009 | Genetic separation of the transplantation tolerance and autoimmune phenotypes in NOD mice |
| Q33291223 | Global unresponsiveness as a mechanism of natural killer cell tolerance in mixed xenogeneic chimeras. |
| Q79086709 | Graft-versus-host-reactive donor CD4 cells can induce T cell-mediated rejection of the donor marrow in mixed allogeneic chimeras prepared with nonmyeloablative conditioning |
| Q41122546 | Hand allotransplantation |
| Q35679173 | Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning |
| Q38309290 | Hematopoietic stem cell infusion/transplantation for induction of allograft tolerance |
| Q36427007 | Hematopoietic stem cell transplantation induces immunologic tolerance in renal transplant patients via modulation of inflammatory and repair processes |
| Q35927610 | Heterogeneity within T Cell Memory: Implications for Transplant Tolerance |
| Q35583521 | Heterologous immunity: an overlooked barrier to tolerance |
| Q37095317 | Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect |
| Q33731951 | Homeostatic proliferation is a barrier to transplantation tolerance |
| Q37860986 | How to cross immunogenetic hurdles to human embryonic stem cell transplantation |
| Q33848181 | Human T-Cell Development and Thymic Egress: An Infectious Disease Perspective |
| Q36863493 | Human embryonic stem cell derivation and nuclear transfer: impact on regenerative therapeutics and drug discovery |
| Q35094665 | Human pancreatic islet-derived progenitor cell engraftment in immunocompetent mice |
| Q36909564 | Immune tolerance: mechanisms and application in clinical transplantation |
| Q35558501 | Immunobiology of acute graft-versus-host disease |
| Q35953282 | Immunogenicity of human embryonic stem cells: can we achieve tolerance? |
| Q36802900 | Immunogenicity of pluripotent stem cells and their derivatives |
| Q37811391 | Immunologic Aspects and Rejection in Solid Organ Versus Reconstructive Transplantation |
| Q33996931 | Immunosuppression for lung transplantation |
| Q34786983 | Immunotherapy as a means to induce transplantation tolerance |
| Q33629253 | Impact of Mixed Xenogeneic Porcine Hematopoietic Chimerism on Human NK Cell Recognition in a Humanized Mouse Model |
| Q37277174 | Incomplete clonal deletion as prerequisite for tissue-specific minor antigen tolerization |
| Q48254157 | Induced pluripotent stem cell-derived gamete-associated proteins incite rejection of induced pluripotent stem cells in syngeneic mice. |
| Q41912497 | Induced tolerance to rat liver allografts involves the apoptosis of intragraft T cells and the generation of CD4(+)CD25(+)FoxP3(+) T regulatory cells |
| Q84233271 | Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allografts |
| Q34082839 | Induction of chimerism permits low-dose islet grafts in the liver or pancreas to reverse refractory autoimmune diabetes |
| Q34231351 | Induction of mixed chimerism using combinatory cell-based immune modulation with mesenchymal stem cells and regulatory T cells for solid-organ transplant tolerance |
| Q35179356 | Induction of tolerance for islet transplantation for type 1 diabetes |
| Q36617576 | Lack of antidonor alloantibody does not indicate lack of immune sensitization: studies of graft loss in a haploidentical hematopoietic cell transplantation swine model |
| Q44482849 | Lack of role for CsA-sensitive or Fas pathways in the tolerization of CD4 T cells via BMT and anti-CD40L. |
| Q78475407 | Long-term feto-maternal microchimerism: nature's hidden clue for alternative donor hematopoietic cell transplantation? |
| Q34496604 | Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. |
| Q34786946 | Mechanisms of transplant tolerance induction using costimulatory blockade |
| Q38053175 | Minimizing immunosuppression in hand transplantation |
| Q35117984 | Minitransplants: allogeneic stem cell transplantation with reduced toxicity |
| Q36453408 | Modifying graft immunogenicity and immune response prior to transplantation: potential clinical applications of donor and graft treatment. |
| Q37622501 | Modulation of allogeneic CD8+ T-cell response by DZNep controls GVHD while preserving hematopoietic chimerism |
| Q37677563 | Mouse models in bone marrow transplantation and adoptive cellular therapy |
| Q34590684 | Mouse models with human immunity and their application in biomedical research |
| Q45865159 | NUP98-HOXA10hd-expanded hematopoietic stem cells efficiently reconstitute bone marrow of mismatched recipients and induce tolerance |
| Q34352679 | Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection |
| Q35146722 | Negative T cell costimulation and islet tolerance. |
| Q75217672 | No tolerance for depletion |
| Q74681820 | Normal donor bone marrow is superior to Flt3 ligand-mobilized bone marrow in prolonging heart allograft survival when combined with anti-CD40L (CD154) |
| Q40494164 | Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism |
| Q36152685 | Organ transplantation--how much of the promise has been realized? |
| Q35634710 | Pathophysiology of acute graft-versus-host disease |
| Q36156559 | Pathophysiology of acute graft-versus-host disease: recent advances |
| Q73343644 | Permanent acceptance of both cardiac and skin allografts using a mild conditioning regimen for the induction of stable mixed chimerism in mice |
| Q33871518 | Pharmacologic modulation of niche accessibility via tyrosine kinase inhibition enhances marrow and thymic engraftment after hematopoietic stem cell transplantation. |
| Q35826497 | Postnatal donor lymphocytes enhance prenatally-created chimerism at the risk of graft-versus-host disease. |
| Q42972562 | Potential role of host effector memory CD8+ T cells in marrow rejection after mixed chimerism induction in cynomolgus monkeys |
| Q34585878 | Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes |
| Q37122367 | Primate models in organ transplantation |
| Q57712641 | Quantitative real-time ARMS-qPCR for mitochondrial DNA enables accurate detection of microchimerism in renal transplant recipients |
| Q35621984 | Regulatory T cells for tolerance therapy: revisiting the concept |
| Q34792489 | Reprogramming the immune system |
| Q34078646 | Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero |
| Q35377258 | Role of HLA‐G and NCR in protection of umbilical cord blood haematopoietic stem cells from NK cell mediated cytotoxicity |
| Q35671669 | Routes to transplant tolerance versus rejection; the role of cytokines. |
| Q83725199 | Serum levels of interleukin (IL)-10, IL-17, transforming growth factor (TGF)-β1, and interferon-γ cytokines and expression levels of IL-10 and TGF-β1 genes in renal allograft recipients after donor bone marrow cell infusion |
| Q37656274 | Should microchimerism turn into rejection prophylactics? |
| Q36954616 | Skin tolerance: in search of the Holy Grail. |
| Q37337098 | Stable mixed chimerism and tolerance to human organ transplants |
| Q34988364 | Stem cell medicine encounters the immune system |
| Q35047249 | Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus |
| Q77580191 | Stemming the tide of rejection |
| Q51392642 | Survival time of cardiac allografts prolonged by isogeneic BMT in mice. |
| Q36963222 | T cell recognition and immunity in the fetus and mother |
| Q35757969 | T-cell depletion eliminates the development of cardiac allograft vasculopathy in mice rendered tolerant by the induction of mixed chimerism |
| Q38150101 | Targeting co-stimulatory pathways: transplantation and autoimmunity |
| Q51776242 | The challenge of immunogenicity in the quest for induced pluripotency. |
| Q33914718 | The changed balance of regulatory and naive T cells promotes tolerance after TLI and anti-T-cell antibody conditioning |
| Q35058547 | The complementary roles of deletion and regulation in transplantation tolerance |
| Q37112199 | The effects of antibody treatment on regulatory CD4(+)CD25(+) T cells |
| Q50692950 | The immunity of splenic and peritoneal F4/80(+) resident macrophages in mouse mixed allogeneic chimeras. |
| Q37792295 | The immunomodulatory properties of mesenchymal stem cells: implications for surgical disease. |
| Q36530319 | The last 5 years of basic science investigation in transplant immunology |
| Q78339275 | The nature and mechanisms of DN regulatory T-cell mediated suppression |
| Q35206940 | The new immunosuppression |
| Q34360541 | Therapeutic approaches for transplantation. |
| Q35893656 | Tolerance induction in clinical transplantation |
| Q38074155 | Tolerance induction strategies in vascularized composite allotransplantation: mixed chimerism and novel developments. |
| Q35711560 | Tolerance mechanisms and recent progress |
| Q37288737 | Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview. |
| Q83956260 | Towards the identification of biomarkers of transplantation tolerance |
| Q37403731 | Translating transplantation tolerance in the clinic: where are we, where do we go? |
| Q37894465 | Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction |
| Q36447590 | Transplant tolerance in non-human primates: progress, current challenges and unmet needs |
| Q26751022 | Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms |
| Q37784380 | Transplantation tolerance through mixed chimerism |
| Q35107006 | Transplantation tolerance: Clinical potential of regulatory T cells |
| Q40043395 | Transplantation: moving to the next level |
| Q36148421 | Treatment of severe autoimmune disease by stem-cell transplantation |
| Q35951541 | Tregs and transplantation tolerance |
| Q38577592 | Vascularized composite allograft tolerance across MHC barriers in a large animal model |
| Q37137178 | Xenotransplantation as a model of integrated, multidisciplinary research |
| Q90429892 | Xenotransplantation: Progress Along Paths Uncertain from Models to Application |
| Q36850147 | Xenotransplantation: current status and a perspective on the future |
Search more.